Diaverum grows its presence in Morocco with new clinic acquisition in Agadir
Diaverum, a leading global renal care provider, established presence in Morocco in 2019 with its first clinic acquisition in Marrakech. Today Diaverum announces the acquisition of the Agadir Hemodialysis Clinic (CHA) in the city of Agadir, an important international tourist destination in the country.
The Agadir Hemodialysis Clinic was founded in 1992 by Doctors Bachir Mounib and Haddou Zemare, both widely considered among the pioneers of renal care development and provision in Morocco. Demand for renal care services across the country is rapidly increasing, with nearly 30,000 patients requiring chronic dialysis treatments.
This acquisition reflects Diaverum’s strong M&A pipeline and long term growth strategy that includes continued geographic expansion in selected, high growth potential markets. The addition of the Agadir Hemodialysis Clinic to its Morocco portfolio will strengthen the role Diaverum plays in the country’s renal care market. Agadir is also a premium tourist destination and will enable the company to extend its d.Holiday programme, which offers patients easy access to Diaverum’s life enhancing renal care when they travel.
Hervé Gourgouillon, Diaverum’s Vice President for the region, said: “The CHA dialysis clinic counts on an experienced multidisciplinary team of more than 30 caregivers, providing quality renal care to chronic disease patients. Agadir is a famous tourist city, and once the world overcomes the global COVID-19 pandemic, we will be able to offer our patients around the world another attractive holiday destination covered by our d.Holiday programme. It is with great pride that I welcome all of the Agadir team into Diaverum, and I am looking forward to working with them."
Dr. Bachir Mounib, CHA co-founder and nephrologist, said: "I welcome this integration into the Diaverum Group. Its international presence, high quality standards and proven efficiency in care delivery will allow us to develop our renal care services even further, with special focus on patient experience."
Dr. Haddou Zemare, CHA co-founder and nephrologist, adds: “Being part of the Diaverum family will also allow us to further improve our infrastructure, equipment and digital capabilities, in order to continue to provide Agadir patients with high quality renal care, including d.Holiday patients".
Salim Meraouna, Diaverum’s Director of Operations, concludes: "The acquisition of the Agadir Hemodialysis Clinic demonstrates our continuous commitment to our ambitions in Morocco, a country where we wish to become the leading renal care provider. With this acquisition, we will provide more Moroccan patients with access to the highest renal care delivery standards, as well as continue to safeguard their safety and health with our industry-leading COVID-19 policies and global Contingency Plan."
For media inquiries:
Bruno Pamplona Polizio
Director of Global Communications
bruno.polizio@diaverum.com
+44 (0) 7874 853405
About Diaverum:
Diaverum provides life enhancing renal care to patients with Chronic Kidney Disease (CKD), enabling them to live fulfilling lives. Diaverum is a leading global provider in renal care services and the largest independent provider in Europe, and we help some 39,000 patients with 6 million treatments annually. Our focus is haemodialysis, but we offer a portfolio of treatments ranging from preventive care, peritoneal dialysis and home care to coordination of patients’ comorbidities and transplantation services.
CKD is a global and escalating challenge today affecting about 10% of the world’s adult population. It’s primarily caused by lifestyle diseases such as diabetes, and the prevalence is increasing in particular in developing countries. CKD disproportionately affects low income individuals and we ensure that our clinics are a safe and familiar space where all our patients are made to feel welcome.
Diaverum’s vision is to transform renal care, to offer the highest quality of care and empower patients to live a fulfilling life. We work together with payers to reduce total cost of care while partnering with local communities to educate around health and the value of prevention.
At the centre of what we do is our standardised, proprietary care delivery model, enabled by a continuously evolving digital infrastructure. We strive to ensure superior medical outcomes exceeding those demanded by national healthcare systems and we support patients by improving personalized care, ease of use and new services through technology.
Diaverum employs more than 11,000 employees and operates more than 420 clinics in 22 countries globally. Diaverum has its head office in Malmö, Sweden.
http://www.diaverum.com/
